Translational Research
Volume 155, Issue 4 , Pages 170-177 , April 2010

Nuclear factor-kappa B (NFκB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease

  • Rahn Kollander

      Affiliations

    • Vascular Biology Center and Division of Hematology-Oncology-Transplantation Department of Medicine, University of Minnesota Medical School, Minneapolis, Minn
    • ,
  • Anna Solovey

      Affiliations

    • Vascular Biology Center and Division of Hematology-Oncology-Transplantation Department of Medicine, University of Minnesota Medical School, Minneapolis, Minn
    • ,
  • Liming Chang Milbauer

      Affiliations

    • Vascular Biology Center and Division of Hematology-Oncology-Transplantation Department of Medicine, University of Minnesota Medical School, Minneapolis, Minn
    • ,
  • Fuad Abdulla

      Affiliations

    • Vascular Biology Center and Division of Hematology-Oncology-Transplantation Department of Medicine, University of Minnesota Medical School, Minneapolis, Minn
    • ,
  • Robert J. Kelm Jr.

      Affiliations

    • Department of Medicine, University of Vermont, Burlington, Vt
    • ,
  • Robert P. Hebbel

      Affiliations

    • Vascular Biology Center and Division of Hematology-Oncology-Transplantation Department of Medicine, University of Minnesota Medical School, Minneapolis, Minn
    • Corresponding Author InformationReprint requests: Robert P. Hebbel, MD, Mayo Mail Code 480, 420 Delaware Street SE, University of Minnesota, Minneapolis, MN 55455

Received 12 June 2009 ,Revised 23 September 2009 ,Accepted 20 October 2009.

References 

  1. Francis RB, Hebbel RP. Hemostasis. In:  Embury SH,  Hebbel RP,  Steinberg MH,  Mohandas N editor. Sickle cell disease: basic principles and clinical practice. New York: Raven Press; 1994;p. 299–310
  2. Tomer A, Harker LA, Kasey S, Eckman JR. Thrombogenesis in sickle cell disease. J Lab Clin Med. 2001;137:398–407
  3. Solovey A, Kollander R, Shet A, et al. Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood. 2004;104:840–846
  4. Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, Hebbel RP. Reperfusion injury pathophysiology in sickle transgenic mice. Blood. 2000;96:314–320
  5. Kalambur VS, Mahaseh H, Bischof JC, et al. Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. Am J Hematol. 2004;77:117–125
  6. Mahaseth H, Vercellotti GM, Welch TE, et al. Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice. J Lab Clin Med. 2005;145:204–211
  7. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest. 2000;106:411–420
  8. Dk Kaul, Liu XD, Choong S, Belcher JD, Vercellotti GM, Hebbel RP. Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. Am J Physiol Heart Circ Physiol. 2004;87:H293–H301
  9. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000;190:255–266
  10. Bea F, Blessing E, Shelley MI, Shultz JM, Rosenfeld ME. Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation. Atherosclerosis. 2003;167:187–194
  11. Mackman N. Regulation of the tissue factor gene. Thromb Haemost. 1997;78:747–754
  12. Belcher JD, Bryant CJ, Nguyen J, et al. Transgenic sickle mice have vascular inflammation. Blood. 2003;101:3953–3959
  13. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy. Microcirculation. 2004;11:129–151
  14. Oeth PA, Parry GC, Kunsch C, Nantermet P, Rosen CA, Mackman N. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol Cell Biol. 1994;14:3772–3781
  15. Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell. 1995;80:321–330
  16. Voigtlander C, Rand A, Lui S-L, et al. Suppression of tissue factor expression, cofactor activity, and metastatic potential of murine melanoma cells by the N-terminal domain of adenovirus E1A 12S protein. J Cell Biochem. 2002;85:54–71
  17. Xia YF, Ye BQ, Li YD, et al. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol. 2004;173:4207–4217
  18. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Alt Complement Med. 2003;9:161–168
  19. Kaul DK, Kollander R, Mahaseth H, et al. Robust vascular protective effect of hydroxamic acid derivatives in a sickle mouse model of inflammation. Microcirculation. 2006;13:489–497
  20. Sheehan M, Wong HR, Hake PW, Zingarelli B. Protective effects of isohelenin, an inhibitor of nuclear factor kappaB, in endotoxic shock in rats. J Endotoxin Res. 2002;8:99–107
  21. Solovey AA, Solovey AN, Harkness J, Hebbel RP. Modulation of endothelial cell activation in sickle cell disease: a pilot study. Blood. 2001;97:1937–1941
  22. Chavakis T, Kanse SM, Pixley RA, et al. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen. FASEB J. 2001;15:2365–2376
  23. Oliani SM, Paul-Clark MJ, Christian HC, Flower RJ, Perretti M. Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am J Pathol. 2001;158:603–615
  24. Wahl C, Liptay S, Guido A, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998;101:1163–1174
  25. Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood. 2000;96:2451–2459
  26. Perelman N, Selvaraj SK, Batra S, et al. Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood. 2003;102:1506–1514
  27. Dias-da-Motta PM, Arruda VR, Muscará MN, et al. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia. Brit J Haematol. 1996;93:333–340
  28. Hara S, Asada Y, Hatakeyama K, et al. Expression of tissue factor and tissue factor pathway inhibitor in rats lungs with lipopolysaccharide-induced disseminated intravascular coagulation. Lab Invest. 1997;77:581–589
  29. Erlich J, Fearns C, Mathison J, Ulevitch RJ, Mackman N. Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun. 1999;67:2540–2546
  30. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood. 2003;102:2678–2683

 Supported by grants PO1 HL55552, PO1 HL075640, and R01 HL060849 from the National Institutes of Health.

PII: S1931-5244(09)00321-1

doi: 10.1016/j.trsl.2009.10.004

Translational Research
Volume 155, Issue 4 , Pages 170-177 , April 2010

Article Tools

* Image Usage & Resolution